Drugs / Celivarone
Celivarone
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials · 3 missed | ||||||
| Phase 2 | NCT00993382 | Sep 2009 → May 2011 | cardiac rhythm disease | Sanofi | Completed | Missed primary |
| Phase 2 | NCT00232310 | Oct 2005 → Apr 2006 | atrial fibrillation, atrial flutter | Sanofi | Completed | Missed primary |
| Phase 2 | NCT00232297 | Jun 2005 → Feb 2007 | ventricular fibrillation, ventricular tachycardia | Sanofi | Completed | Missed primary |
| Phase 2/31 trial · 1 missed | ||||||
| Phase 2/3 | NCT00233441 | Dec 2004 → May 2006 | atrial fibrillation, atrial flutter | Sanofi | Completed | Missed primary |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Celivarone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00232310 ↗ |
| Known as | Celivarona | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707403 ↗ |
| Known as | K45001587E | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707403 ↗ |
| Known as | Ssr149744 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707403 ↗ |
| Known as | SSR149744C | “CELIVARONE (SSR149744C)” NCT00232310 ↗ |
| Known as | UNII-K45001587E | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707403 ↗ |
| Modality | Small molecule | “Celivarone, a new noniodinated benzofuran derivative pharmacologically related to dronedarone and amiodarone” PMID 22171925 ↗ Dec 2011 |
| Route | Oral | “Route of administration: oral” NCT00993382 ↗ |